Physician profile
Anuja Thatte
NPI 1598287401
$629.03
in general payments reported to CMS, 2019-2025
16 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $98.84 · 2022: $70.72 · 2023: $165 · 2024: $174 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $374 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $374.48 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $120.00 | 2024 | Imfinzi |
| Incyte Corporation | $84.99 | 2023 | |
| G1 Therapeutics, INC. | $80.33 | 2023 | Cosela |
| Merck Sharp & Dohme LLC | $57.52 | 2024-2025 | Keytruda, Keytruda Qlex |
| Glaxosmithkline, LLC. | $44.74 | 2022 | |
| Adaptive Biotechnologies Corporation | $32.71 | 2025 | Clonoseq |
| Abbvie INC. | $31.48 | 2025 | |
| Syndax Pharmaceuticals, INC. | $28.72 | 2025 | Revuforj |
| Janssen Biotech, INC. | $25.98 | 2022 | |
| Pharmacosmos Therapeutics INC. | $23.72 | 2024 | Monoferric |
| Myovant Sciences INC. | $20.59 | 2021 | |
| Emd Serono, INC. | $20.24 | 2021 | |
| Tg Therapeutics, INC. | $16.96 | 2021 | |
| Rigel Pharmaceuticals, INC. | $15.88 | 2021 | |
| Myriad Genetic Laboratories, INC. | $13.05 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pharmacyclics LLC, An Abbvie Company | $12.12 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anuja Thatte listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.